Birth Weight and Age-Specific Analysis of the 1990 US Infant Mortality Drop

Schoendorf, Kenneth C.

doi:10.1001/archpedi.1997.02170390019004

Cited by 40 publications

(19 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…5,42 Improvements in mortality rates were seen in all birth-weight categories; however, infants born between 750 and 1500 g had mortality rates that were significantly lower than in preceding eras. 43 Few infants died primarily of RDS after 1990. However, as more infants born at 23 and 24 weeks' gestation survived, more chronic problems of prematurity were evident, including poor growth, bronchopulmonary dysplasia (BPD), and poor neurodevelopment.…”

Section: Period 4: After 1990mentioning

confidence: 99%

Neonatal Mortality From Respiratory Distress Syndrome: Lessons for Low-Resource Countries

et al. 2011

View full text Add to dashboard Cite

Respiratory distress syndrome (RDS) is a major contributor to neonatal mortality worldwide. However, little information is available regarding rates of RDS-specific mortality in low-income countries, and technologies for RDS treatment are used inconsistently in different health care settings. Our objective was to better understand the interventions that have decreased the rates of RDS-specific mortality in high-income countries over the past 60 years. We then estimated the effects on RDS-specific mortality in low-resource settings. Of the sequential introduction of technologies and therapies for RDS, widespread use of oxygen and continuous positive airway pressure were associated with the time periods that demonstrated the greatest decline in RDS-specific mortality. We argue that these 2 interventions applied widely in low-resource settings, with appropriate supportive infrastructure and general newborn care, will have the greatest impact on decreasing neonatal mortality. This historical perspective can inform policy-makers for the prioritization of scarce resources to improve survival rates for newborns worldwide.

show abstract

Section: Period 4: After 1990mentioning

confidence: 99%

Neonatal Mortality From Respiratory Distress Syndrome: Lessons for Low-Resource Countries

et al. 2011

View full text Add to dashboard Cite

show abstract

“…7 More recently, increased use of antenatal steroids and the availability of surfactant therapy are considered important advances contributing to improved neonatal outcome presumably by decreasing the incidence and severity of conditions associated with preterm births such as respiratory distress syndrome (RDS). [8][9][10][11][12][13] Since males are at higher risk of prematurity and prematurity-related conditions such as RDS, 14,15 it is possible that these advances in therapy could differentially benefit male infants, and as a result, alter the sex difference in mortality.…”

Section: Introductionmentioning

confidence: 99%

Narrowing of Sex Differences in Infant Mortality in Massachusetts

et al. 2004

View full text Add to dashboard Cite

“…20 Although one report found no difference in the percent of blacks that received surfactant compared to whites, antenatal steroid use was more prevalent among the mothers of the white infants. 5 Thus, it is difficult to attribute the increasing disparity in black:white RDS mortality solely to biologic differences in response to surfactant. Race serves as a proxy for social status in the US.…”

Section: Discussionmentioning

confidence: 99%